Cargando…
Free energy perturbation (FEP)-guided scaffold hopping
Scaffold hopping refers to computer-aided screening for active compounds with different structures against the same receptor to enrich privileged scaffolds, which is a topic of high interest in organic and medicinal chemistry. However, most approaches cannot efficiently predict the potency level of...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072250/ https://www.ncbi.nlm.nih.gov/pubmed/35530128 http://dx.doi.org/10.1016/j.apsb.2021.09.027 |
_version_ | 1784701018616889344 |
---|---|
author | Wu, Deyan Zheng, Xuehua Liu, Runduo Li, Zhe Jiang, Zan Zhou, Qian Huang, Yue Wu, Xu-Nian Zhang, Chen Huang, Yi-You Luo, Hai-Bin |
author_facet | Wu, Deyan Zheng, Xuehua Liu, Runduo Li, Zhe Jiang, Zan Zhou, Qian Huang, Yue Wu, Xu-Nian Zhang, Chen Huang, Yi-You Luo, Hai-Bin |
author_sort | Wu, Deyan |
collection | PubMed |
description | Scaffold hopping refers to computer-aided screening for active compounds with different structures against the same receptor to enrich privileged scaffolds, which is a topic of high interest in organic and medicinal chemistry. However, most approaches cannot efficiently predict the potency level of candidates after scaffold hopping. Herein, we identified potent PDE5 inhibitors with a novel scaffold via a free energy perturbation (FEP)-guided scaffold-hopping strategy, and FEP shows great advantages to precisely predict the theoretical binding potencies ΔG(FEP) between ligands and their target, which were more consistent with the experimental binding potencies ΔG(EXP) (the mean absolute deviations [Formula: see text] < 2 kcal/mol) than those ΔG(MM-PBSA) or ΔG(MM-GBSA) predicted by the MM-PBSA or MM-GBSA method. Lead L12 had an IC(50) of 8.7 nmol/L and exhibited a different binding pattern in its crystal structure with PDE5 from the famous starting drug tadalafil. Our work provides the first report via the FEP-guided scaffold hopping strategy for potent inhibitor discovery with a novel scaffold, implying that it will have a variety of future applications in rational molecular design and drug discovery. |
format | Online Article Text |
id | pubmed-9072250 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-90722502022-05-07 Free energy perturbation (FEP)-guided scaffold hopping Wu, Deyan Zheng, Xuehua Liu, Runduo Li, Zhe Jiang, Zan Zhou, Qian Huang, Yue Wu, Xu-Nian Zhang, Chen Huang, Yi-You Luo, Hai-Bin Acta Pharm Sin B Original Article Scaffold hopping refers to computer-aided screening for active compounds with different structures against the same receptor to enrich privileged scaffolds, which is a topic of high interest in organic and medicinal chemistry. However, most approaches cannot efficiently predict the potency level of candidates after scaffold hopping. Herein, we identified potent PDE5 inhibitors with a novel scaffold via a free energy perturbation (FEP)-guided scaffold-hopping strategy, and FEP shows great advantages to precisely predict the theoretical binding potencies ΔG(FEP) between ligands and their target, which were more consistent with the experimental binding potencies ΔG(EXP) (the mean absolute deviations [Formula: see text] < 2 kcal/mol) than those ΔG(MM-PBSA) or ΔG(MM-GBSA) predicted by the MM-PBSA or MM-GBSA method. Lead L12 had an IC(50) of 8.7 nmol/L and exhibited a different binding pattern in its crystal structure with PDE5 from the famous starting drug tadalafil. Our work provides the first report via the FEP-guided scaffold hopping strategy for potent inhibitor discovery with a novel scaffold, implying that it will have a variety of future applications in rational molecular design and drug discovery. Elsevier 2022-03 2021-09-30 /pmc/articles/PMC9072250/ /pubmed/35530128 http://dx.doi.org/10.1016/j.apsb.2021.09.027 Text en © 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Wu, Deyan Zheng, Xuehua Liu, Runduo Li, Zhe Jiang, Zan Zhou, Qian Huang, Yue Wu, Xu-Nian Zhang, Chen Huang, Yi-You Luo, Hai-Bin Free energy perturbation (FEP)-guided scaffold hopping |
title | Free energy perturbation (FEP)-guided scaffold hopping |
title_full | Free energy perturbation (FEP)-guided scaffold hopping |
title_fullStr | Free energy perturbation (FEP)-guided scaffold hopping |
title_full_unstemmed | Free energy perturbation (FEP)-guided scaffold hopping |
title_short | Free energy perturbation (FEP)-guided scaffold hopping |
title_sort | free energy perturbation (fep)-guided scaffold hopping |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072250/ https://www.ncbi.nlm.nih.gov/pubmed/35530128 http://dx.doi.org/10.1016/j.apsb.2021.09.027 |
work_keys_str_mv | AT wudeyan freeenergyperturbationfepguidedscaffoldhopping AT zhengxuehua freeenergyperturbationfepguidedscaffoldhopping AT liurunduo freeenergyperturbationfepguidedscaffoldhopping AT lizhe freeenergyperturbationfepguidedscaffoldhopping AT jiangzan freeenergyperturbationfepguidedscaffoldhopping AT zhouqian freeenergyperturbationfepguidedscaffoldhopping AT huangyue freeenergyperturbationfepguidedscaffoldhopping AT wuxunian freeenergyperturbationfepguidedscaffoldhopping AT zhangchen freeenergyperturbationfepguidedscaffoldhopping AT huangyiyou freeenergyperturbationfepguidedscaffoldhopping AT luohaibin freeenergyperturbationfepguidedscaffoldhopping |